ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC Begins Reassessment of Year 2000 Goals; Advisors Discuss A ‘More Dynamic Model’

May 22, 1992

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988